Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis
Journal of the Korean Neurological Association · 01.05.2026 · 44 (2) · 124-133
DOI: 10.17340/jkna.2025.0062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Korean Neurological Association, online erschienen am 01.05.2026. Verfasst von Seong-il Oh. Die Arbeit nennt 58 Literaturangaben. Gefördert von: CN Research Foundation for Rare Disease.
Abstract (Originalsprache)
The treatment paradigm for neuromuscular diseases, especially myasthenia gravis and amyotrophic lateral sclerosis, has recently shifted with the emergence of mechanism-based and precision therapies. In myasthenia gravis, improved understanding of antibody-mediated pathology has enabled the clinical adoption of targeted immunotherapies, including complement inhibitors and neonatal Fc receptor antagonists, resulting in meaningful benefits for refractory disease and a shift beyond conventional immunosuppression. In amyotrophic lateral sclerosis, while multidisciplinary care remains fundamental, recent advances highlight a gradual move toward precision medicine through platform trial designs, biomarker-informed evaluation, and gene-specific molecular therapies for selected patient subgroups. Together, these developments reflect a paradigm shift from uniform treatment strategies to individualized, pathophysiology-driven clinical decision-making. This review summarizes recent guideline updates and key clinical trial evidence, illustrating how advances in immunopathology, genetics, and trial methodology are redefining contemporary neuromuscular care.
Förderung
- CN Research Foundation for Rare Disease
Zitieren
APA
Oh, S. (2026). Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis. Journal of the Korean Neurological Association, 44(2), 124-133. https://doi.org/10.17340/jkna.2025.0062
Vancouver
Oh S. Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis. Journal of the Korean Neurological Association. 2026;44(2):124-133. doi:10.17340/jkna.2025.0062
BibTeX
@article{Oh2026,
author = {Oh, Seong-il},
title = {Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis},
journal = {Journal of the Korean Neurological Association},
year = {2026},
volume = {44},
number = {2},
pages = {124--133},
doi = {10.17340/jkna.2025.0062}
}
EUVIMED